Provisional patent for weight loss compound
Friday, 27 February, 2009
Diagnostics company HealthLinx and industry group Dairy Australia have filed a provisional patent for a dairy-derived bioactive compound that has shown weight loss potential in rats.
The compound, LAP001, was identified from fractionated proteins in dairy products. It was found to reduce the production and storage of fat in rat cells.
The activity was confirmed by an independent research institute, HealthLinx said in a statement. Further analysis is being undertaken.
HealthLinx said there was the potential to develop the compound as a nutraceutical.
Five scenarios for the future of Antarctic life
A team of Australian and international researchers have predicted five possible outcomes for how...
Could this biosensor bypass labs with onsite PFAS detection?
La Trobe University has developed a portable biosensor that may allow rapid, onsite detection of...
How a tiny worm changed a decade of scientific thinking
A tiny roundworm has helped University of Queensland scientists rethink the way sensory nerve...
